GMED - News), a St. Louis, Missouri-based Next Generation Disease Management company, announced today that it successfully treated its fourteenth patient with presumed West Nile virus encephalitis.
The patient is a previously healthy woman from Sacramento, California who developed fever, headache, and vomiting and was admitted to the hospital with presumed West Nile virus on Monday of this week. On Tuesday she began receiving GenoMed's protocol, and on Wednesday she was again alert and laughing. She was discharged from hospital yesterday.
The patient's Infectious Disease consultant knew about GenoMed's protocol. GenoMed's protocol was approved by the hospital's Institutional Review Board earlier this summer.
David Moskowitz MD, FACP, GenoMed's Chief Medical Officer and CEO, commented, "This patient demonstrated an extremely rapid resolution of her symptoms, several days faster than expected. Normally it takes 3-6 days to recover from West Nile virus meningo-encephalitis. This patient's recovery time was 24 hours."
During the past three summers, GenoMed has treated 17 patients, of whom this patient represents the 14th treatment success (82%).
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
